Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • doublehelix82
    Junior Member
    • Dec 2010
    • 5

    transcripts, transfrags, TARs, TUFs, ...

    Hello,
    I am having trouble with understanding these (in the title). Let me try to explain my understanding and confusion and I would greatly appreciate it if anybody could comment on that.

    transcript: An mRNA copy of a gene. This is the whole processed mRNA copy of the gene at hand.
    transfrags (Transcribed fragment): A fragment that is found to be transcribed. (How?)
    TAR (Transcriptionally active region): In the literature, I have seen TARs in the context of RNA-seq experiments, i.e., TAR is a region which is expressed according to an RNA-seq experiment.
    TUF (Transcript of unknown function): A transcript in the cell whose function could not be determined. I am pretty confused about how these are discovered.

    If these are correct, ESTs are, I think, transfrags (is that right?). But I do not understand the difference between TARs and TUFs. I think TARs are regions (without exact boundaries) that show transcriptional activity, but TUFs are actual mRNA sequences which are found in the cell (whose function could not be understood.) Most of the papers use the terms assuming that you already know what they are talking about. I would greatly appreciate it if you could elaborate on those or point me to some basic resources. Thanks!

    DH.
  • steven
    Senior Member
    • Aug 2009
    • 269

    #2
    Hi,
    As you pointed out, there is no clear standard for all this nomenclature, but here is my point of view:

    A transcript is an RNA molecule. It can be mRNA, but also tRNA, miRNA, piRNA, PASR, lncRNA, tiRNA, etc. I would say TUF is used when the function of the transcript is unknown (usually non coding).

    Transfrags is a term that was frequently used in the microarray world (i know it from tiling arrays). It is a genomic area identified by a microarray experiment where cellular RNA material is dumped on a chip. The signal indicates a genomic region with transcriptional activity, but you do not know the precise transcript structure. Different transfrags can belong to the same transcript (i.e. from different exons) but there is no connectivity information. Also, one transfrag can be generated by two overlapping exons from different isoforms -the signal is projected at the genomic level. Anyway.
    I would say that TAR is the same, but was used in the context of RNA-seq. Again, this term describes a genomic region, not an RNA molecule. It may be a generic term.

    ESTs are (not so) short sequences produced by "old-generation" transcript sequencing. They are supposed to indicate parts of mRNA.

    Therefore, if you find ESTs, transfrags and RNA-seq reads over a genomic region, it is probably a TAR!

    Comment

    • bagdevi
      Junior Member
      • May 2011
      • 4

      #3
      Thanks for the description of each term.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      28 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Working...